Helen TodmanProject Director at Parexel International, UK
Helen has 18+ years of progressive clinical research experience in pharma, CRO and biotech. Her experience includes leadership and management in the operational oversight of multi-therapeutic, global Phase I-IV drug/biologic trials along with clinical research experience in various therapeutic concentrations. Helen has managed all phases of the project lifecycle on Phase I to Phase IV studies and has worked on the first hybrid virtual trial run by Parexel, which included managing the innovative technology vendors used on the study. She has also worked on several virtual trial workshops and is heavily involved in the virtual trial initiative within Parexel. Most recently, Helen has led global cross-functional teams to successfully deliver on both clinical programs and operational initiatives and is a subject matter expert for a program of studies as part of a sponsor portfolio. She has been involved in several aspects of clinical trial development including the development of CRFs, clinical databases for a psychiatric academic grant, as well as mentoring, audit training and preparation. Helen has an MSc in International Management from Manchester Business School, UK.